Updates On the ASCO 2022 Annual Meeting Updates On the ASCO 2022 Annual Meeting havensmith 2 years ago
Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Ve... Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Versus bevacizumab (BE... havensmith 2 years ago
Making Way For Immunotherapy In The GI Cancers, Durvalu... Making Way For Immunotherapy In The GI Cancers, Durvalumab To Become The Ne... havensmith 2 years ago
Junshi’s domestic Toripalimab’s significant results in... Junshi’s domestic Toripalimab’s significant results in recurrent or metasta... havensmith 2 years ago